FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094161067> ?p ?o ?g. }

• W2094161067 endingPage "280" @default.
• W2094161067 startingPage "275" @default.
• W2094161067 abstract "Molecules that are highly expressed by human prostate cancers may serve as therapeutically relevant targets or tumor markers. Tyrosine kinases are frequently overexpressed in metastatic tumor cells and this prompted us to screen for tyrosine kinases that are overexpressed in prostate cancer cells.Expression levels of the EphA2 receptor tyrosine kinase were determined by Western blot analysis in canine and human prostate cancer cell lines and in immortalized and transformed variants of 267B1 prostatic epithelial cells. EphA2 levels in benign human prostate and prostate cancers were also determined in formalin-fixed, paraffin-embedded tissues using immunohistochemical staining.Metastatic prostate cancer cells overexpressed EphA2 by 10-100 fold as compared with non-invasive prostatic epithelial cells. EphA2 immunoreactivity in vivo was also significantly greater in human prostate cancers as compared with benign prostate epithelium.The EphA2 receptor tyrosine kinase is differentially expressed in human and canine prostate cancer cell lines and overexpressed in human prostate cancers as compared with benign prostate tissues. Metastasis-derived canine prostate carcinoma cell lines overexpress EphA2 and may provide pre-clinical models to further evaluate the role of EphA2 in prostate carcinogenesis. Further investigations are needed to determine the utility of EphA2 as a tumor marker and a novel target in human prostate cancer." @default.
• W2094161067 created "2016-06-24" @default.
• W2094161067 creator A5009558693 @default.
• W2094161067 creator A5011112601 @default.
• W2094161067 creator A5019272496 @default.
• W2094161067 creator A5033280911 @default.
• W2094161067 creator A5041113439 @default.
• W2094161067 creator A5041766764 @default.
• W2094161067 creator A5046763527 @default.
• W2094161067 creator A5048482314 @default.
• W2094161067 creator A5087872496 @default.
• W2094161067 date "1999-12-01" @default.
• W2094161067 modified "2023-10-01" @default.
• W2094161067 title "Overexpression of the EphA2 tyrosine kinase in prostate cancer" @default.
• W2094161067 cites W1970193090 @default.
• W2094161067 cites W2012865220 @default.
• W2094161067 cites W2029998039 @default.
• W2094161067 cites W2036446081 @default.
• W2094161067 cites W2040291225 @default.
• W2094161067 cites W2053099268 @default.
• W2094161067 cites W2059817089 @default.
• W2094161067 cites W2063844198 @default.
• W2094161067 cites W2064795291 @default.
• W2094161067 cites W2069019173 @default.
• W2094161067 cites W2079878541 @default.
• W2094161067 cites W2083158374 @default.
• W2094161067 cites W2093776977 @default.
• W2094161067 cites W2102249975 @default.
• W2094161067 cites W2140016888 @default.
• W2094161067 cites W4230112911 @default.
• W2094161067 doi "https://doi.org/10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t" @default.
• W2094161067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10544301" @default.
• W2094161067 hasPublicationYear "1999" @default.
• W2094161067 type Work @default.
• W2094161067 sameAs 2094161067 @default.
• W2094161067 citedByCount "241" @default.
• W2094161067 countsByYear W20941610672012 @default.
• W2094161067 countsByYear W20941610672013 @default.
• W2094161067 countsByYear W20941610672014 @default.
• W2094161067 countsByYear W20941610672015 @default.
• W2094161067 countsByYear W20941610672016 @default.
• W2094161067 countsByYear W20941610672017 @default.
• W2094161067 countsByYear W20941610672018 @default.
• W2094161067 countsByYear W20941610672019 @default.
• W2094161067 countsByYear W20941610672020 @default.
• W2094161067 countsByYear W20941610672021 @default.
• W2094161067 countsByYear W20941610672022 @default.
• W2094161067 countsByYear W20941610672023 @default.
• W2094161067 crossrefType "journal-article" @default.
• W2094161067 hasAuthorship W2094161067A5009558693 @default.
• W2094161067 hasAuthorship W2094161067A5011112601 @default.
• W2094161067 hasAuthorship W2094161067A5019272496 @default.
• W2094161067 hasAuthorship W2094161067A5033280911 @default.
• W2094161067 hasAuthorship W2094161067A5041113439 @default.
• W2094161067 hasAuthorship W2094161067A5041766764 @default.
• W2094161067 hasAuthorship W2094161067A5046763527 @default.
• W2094161067 hasAuthorship W2094161067A5048482314 @default.
• W2094161067 hasAuthorship W2094161067A5087872496 @default.
• W2094161067 hasConcept C101544691 @default.
• W2094161067 hasConcept C121608353 @default.
• W2094161067 hasConcept C126322002 @default.
• W2094161067 hasConcept C142724271 @default.
• W2094161067 hasConcept C150582083 @default.
• W2094161067 hasConcept C170493617 @default.
• W2094161067 hasConcept C204232928 @default.
• W2094161067 hasConcept C2776235491 @default.
• W2094161067 hasConcept C2779013556 @default.
• W2094161067 hasConcept C2780192828 @default.
• W2094161067 hasConcept C42362537 @default.
• W2094161067 hasConcept C502942594 @default.
• W2094161067 hasConcept C71924100 @default.
• W2094161067 hasConcept C86803240 @default.
• W2094161067 hasConcept C87874733 @default.
• W2094161067 hasConceptScore W2094161067C101544691 @default.
• W2094161067 hasConceptScore W2094161067C121608353 @default.
• W2094161067 hasConceptScore W2094161067C126322002 @default.
• W2094161067 hasConceptScore W2094161067C142724271 @default.
• W2094161067 hasConceptScore W2094161067C150582083 @default.
• W2094161067 hasConceptScore W2094161067C170493617 @default.
• W2094161067 hasConceptScore W2094161067C204232928 @default.
• W2094161067 hasConceptScore W2094161067C2776235491 @default.
• W2094161067 hasConceptScore W2094161067C2779013556 @default.
• W2094161067 hasConceptScore W2094161067C2780192828 @default.
• W2094161067 hasConceptScore W2094161067C42362537 @default.
• W2094161067 hasConceptScore W2094161067C502942594 @default.
• W2094161067 hasConceptScore W2094161067C71924100 @default.
• W2094161067 hasConceptScore W2094161067C86803240 @default.
• W2094161067 hasConceptScore W2094161067C87874733 @default.
• W2094161067 hasIssue "4" @default.
• W2094161067 hasLocation W20941610671 @default.
• W2094161067 hasLocation W20941610672 @default.
• W2094161067 hasOpenAccess W2094161067 @default.
• W2094161067 hasPrimaryLocation W20941610671 @default.
• W2094161067 hasRelatedWork W1980245127 @default.
• W2094161067 hasRelatedWork W1984161344 @default.
• W2094161067 hasRelatedWork W2094161067 @default.
• W2094161067 hasRelatedWork W2132803044 @default.
• W2094161067 hasRelatedWork W2350150832 @default.

• next